Dog /

Breed profile · FDA CVM July 2026 extract

Basset - Fawn Brittany adverse-event record

Adverse-event filings for Basset - Fawn Brittany (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#364 of 510
by report volume (all breeds)
19
FDA CVM reports on file
0.0%
death-coded share of reports
7
Lack of efficacy - NOS - top reaction

How the 19 reports break down

By recorded gender -- every report on file for Basset - Fawn Brittany, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 6 4.5 3 1.5 0 2012 2013 2014 2015 2016 2017 2019 2021 Reports filed Death-coded reports
Annual report volume for Basset - Fawn Brittany drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Basset - Fawn Brittany ranks #364 of 510 by total reports (19). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#364
This breed, reports of 510

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Basset - Fawn Brittany has 19 reports now versus 19 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Basset - Fawn Brittany changes

Total Reports

19

Below-median volume

Deaths Reported

0

of 19 reports

Death-coded share of reports

0.0%

0.0% death-coded

Avg Age at Report

6.2 yr

20.4 kg avg weight

Death-Coded Outcome Share

Basset - Fawn Brittany death-coded reports 0.0%
Cross-breed median

0.0% of 19 basset - fawn brittany reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 20.4 kg (45.0 lbs)

Top Reported Reactions

Lack of efficacy - NOS 7
Lethargy (see also Central nervous system depression in 'Neurological') 3
INEFFECTIVE, HEARTWORM LARVAE 3
Emesis 2
Lack of efficacy (endoparasite) - hookworm 2

Most Referenced Drugs

Milbemycin Oxime + Spinosad 15
Spinosad 2
Milbemycin Oxime + Praziquantel 2
Betamethasone + Florfenicol + Terbinafine 1
Clomipramine 1

Outcome Breakdown

Outcome Unknown
11 (57.9%)
Recovered/Normal
7 (36.8%)
Recovered with Sequela
1 (5.3%)

Gender Distribution

Male 14 (73.7%)
Female 5 (26.3%)

Reports by Year

Year Reports Trend
2012 2
2013 4
2014 1
2015 6
2016 2
2017 1
2019 2
2021 1

Basset - Fawn Brittany: low death-coded share in the FDA CVM extract

Signature read: 19 reports place Basset - Fawn Brittany in the lower third of breed filing volume (#364 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Basset - Fawn Brittany sits at #364 of 510 by report volume among all breeds and #237 of 298 among dog breeds, with 19 reports and 0 (0.0%) death-coded. Mean age at report: 6.2 years, average weight 20.4 kg (45.0 lbs).

Top reported signs: Lack of efficacy - NOS (7), Lethargy (see also Central nervous system depression in 'Neurological') (3), INEFFECTIVE, HEARTWORM LARVAE (3). Most-referenced drug: Milbemycin Oxime + Spinosad (15 reports), followed by Spinosad (2) and Milbemycin Oxime + Praziquantel (2).

Outcome coding on 19 status-recorded reports is dominated by Outcome Unknown (57.9%). Annual submissions ranged 1-2,021 across 8 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Sparse-volume peer sets for Basset - Fawn Brittany drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar average weight

Nearest other-species breeds by reported average weight (20.4 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Basset - Fawn Brittany?
There are 19 adverse event reports involving Basset - Fawn Brittany in the FDA database, of which 0 were death-coded (0.0% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Basset - Fawn Brittany ranks #364 of 510 by report volume among all breeds PlainBreed indexes (#237 of 298 among dog breeds).
Where does Basset - Fawn Brittany sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Basset - Fawn Brittany is #364 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #237 of 298. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Basset - Fawn Brittany?
The most commonly reported adverse reactions for Basset - Fawn Brittany are Lack of efficacy - NOS (7 reports), Lethargy (see also Central nervous system depression in 'Neurological') (3 reports), INEFFECTIVE, HEARTWORM LARVAE (3 reports), Emesis (2 reports), Lack of efficacy (endoparasite) - hookworm (2 reports).
What drugs are most frequently associated with Basset - Fawn Brittany adverse events?
The drugs most frequently referenced in Basset - Fawn Brittany adverse event reports are Milbemycin Oxime + Spinosad (15 reports), Spinosad (2 reports), Milbemycin Oxime + Praziquantel (2 reports), Betamethasone + Florfenicol + Terbinafine (1 reports), Clomipramine (1 reports).
What is the average age of Basset - Fawn Brittany in adverse event reports?
The average age of Basset - Fawn Brittany at the time of adverse event reports is 6.2 years, with an average weight of 20.4 kg (45.0 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Basset - Fawn Brittany (Dog), extract as of July 2026 extract. 19 reports · 0 death-coded (0.0% of reports, not a mortality rate) · #364 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →